Societal CDMO Inc (NAS:SCTL)
$ 1.1 0.01 (0.92%) Market Cap: 121.61 Mil Enterprise Value: 155.86 Mil PE Ratio: 0 PB Ratio: 1.97 GF Score: 32/100

Q2 2021 Recro Pharma Inc Earnings Call Transcript

Aug 09, 2021 / 08:30PM GMT
Release Date Price: $1.96 (+3.70%)
Operator

Hello, thank you for standing by, and welcome to the Recro Second Quarter 2021 Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Stephanie Diaz, Investor Relations. Please go ahead.

Stephanie Diaz
Vida Strategic Partners Inc. - President & CEO

Thank you. Hello, and thank you for joining us. On today's call, we have David Enloe, President and CEO; and Ryan Lake, Chief Financial Officer.

Today, we will be providing an update overview of Recro's contract development and manufacturing business, including updates on corporate activities and financial results for the quarter ended June 30, 2021. After our prepared remarks, we will welcome your questions.

Before we begin, I'd like to caution that comments made during this conference call today, August 9, 2021, will contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot